Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS spends £26 million on consultancy

December 18, 2018
Manufacturing and Production BMA, Consultancy, Jobs, NHS, health

Private consultancy firms were paid at least £26 million as part of a reorganisation of the NHS, in what has …

News

Celltrion and Teva’s Herceptin biosimilar secures FDA approval in breast cancer

December 18, 2018
Manufacturing and Production, Sales and Marketing Herceptin, Herzuma, Teva, celltrion, pharma

Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by …

News

Eli Lilly’s Taltz shows superiority over AbbVie’s Humira

December 18, 2018
Manufacturing and Production Eli Lilly, Humira, Taltz, arthritis, immune system

A study has found that Eli Lilly’s Taltz (ixekizumab) met the primary, and all secondary endpoints, in patients with active …

News
johnson_and_johnson_jj

J&J announces $5bn share repurchase

December 18, 2018
Manufacturing and Production J&J, JJ, Shares, asbestos, baby powder, reuters, scandal

New Jersey-based pharma firm Johnson & Johnson plans to buy back $5 billion in shares after news agency Reuters released …

News
pharmafile_autumn_2018

The Autumn 2018 edition of Pharmafile is available to read online now!

December 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunology, infectious diseases, pharma, pharmafile, rare diseases

The Autumn 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

News

NHS overcrowding leads to ambulances being turned away

December 17, 2018
Sales and Marketing Hopsitals, NHS, UK, health, politics

NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above …

News
novartis_outside_1

Novartis withdraw marketing application for heart drug

December 17, 2018
Sales and Marketing CHMP, EMA, MI, Novartis, pharma

Swiss multinational Novartis has withdrawn a European Medicines Agency (EMA) marketing application for canakinumab for the prevention of serious events …

News
bms_nassau_park_new_jersey

CHMP approve Bristol-Myers Squibb’s Sprycel for paediatric patients with Ph+ ALL

December 17, 2018
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Sprycel, all

New Jersey-based firm Bristol -Myers Squibb today announced that the Committee for Medicinal Products for Human Use (CHMP) of the …

News
4768764591_9e4f7f0eb8_z

No-deal Brexit stockpiling puts pressure on supply chain

December 17, 2018
Sales and Marketing brexit, no-deal, pharma, pricing, supply chain

The stockpiling of medicines in preparation for a no-deal Brexit is putting pressure on the supply chain and causing shortages …

News

J&J shares plummet after asbestos cover up allegations emerge

December 17, 2018
Sales and Marketing J&J, JJ, Johnson & Johnson, asbestos, reuters

Shares in American healthcare firm Johnson & Johnson plummeted on Friday after news agency Reuters reported that the New Jersey-based …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10

Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …

News
scotland-1761292_960_720

‘Significant’ health outcomes gap still exists in Scotland

December 14, 2018
Medical Communications NHS, Scotland, UK, health, inequality

There is a significant gap in health outcomes between the most and least deprived areas of Scotland, a Scottish government …

News

Data reveals November’s performance was worst on record for NHS

December 14, 2018
Medical Communications NHS, NHS England, UK, funding, investment, wait times

November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …

News
york-492566_960_720

York-based biotech expands premises after $2.2 million investment

December 14, 2018
Medical Communications UK, aptamer, biotech, funding, investment, york science park

The York-based Aptamer Group is set to expand its premises after securing $2.2 million in overseas investment in June of …

News

Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m

December 13, 2018
Business Services GI, IBS, basuch, cnstipation, synergy pharma

Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch …

News
msd

MSD announced collaboration with Brazilian non-profit over development of dengue vaccine

December 13, 2018
Business Services, Medical Communications, Research and Development Dengue fever, HPV, hepatitis a, vaccines, virus

US firm Merck & Co have announced a collaboration with the Brazilian non-profit Instituto Butantan, with the intention of developing …

News
yorkshire_moors_dales_yorkshire_landscape_england_countryside_english_rural-497670

Those living in rural areas less likely to survive cancer, study shows

December 13, 2018
Medical Communications, Research and Development Cancer, health, oncology, rural, survival, urban

Those living in rural areas are less likely to survive cancer than their city dwelling counterparts, according to new research …

News

Government choose England top pharmacist to address overprescribing and polypharmacy

December 13, 2018
Medical Communications, Research and Development England, Matt Hancock, NHS, medicine, pharma

England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS. The move …

News

NICE reject two treatments for fatal, ultra-rare disease – hATTR

December 13, 2018
Medical Communications, Research and Development, Sales and Marketing

The NHS’ cost effectiveness body NICE has rejected two treatments for the rare inherited condition, hereditary transthyretin-related amyliodsis (hATTR), over …

News
pharmafocus_dec_2018_cover

The December issue of Pharmafocus is available to read online now!

December 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eisai, GSK, Gilead, Mundipharma, Pharmafocus, mesothelioma, pharma

The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026